• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Philips buys into $250M health technology fund

Philips buys into $250M health technology fund

August 17, 2010 By MedCity News

MedCity News logo

The Dutch parent of Philips Healthcare joined a $250 million venture fund that will invest in innovative early and growth-stage healthcare technology companies in Europe and the United States.

Royal Philips Electronics Inc. (NYSE:PHG) made an undisclosed “minority share” investment in Gilde Healthcare III, which will invest in home healthcare solutions, sleep improvement techniques, image-guided interventions and therapies and clinical decision support with emphasis on cardiology, oncology and women’s health.

These so-called patient-centric healthcare solutions, medical technologies and therapeutics are beginning to focus on patient experience and improved clinical outcome, Philips said.

Philips, which employs 1,100 people at its global computed tomography and nuclear medicine businesses in Highland Heights, Ohio, is making the investment to “foster innovation in areas of strategic interest to its healthcare business,” the company said in a release. Two months ago, Philips said it would invest $33.4 million in the Philips Healthcare Global Advanced Imaging Innovation Center at University Hospitals Case Medical Center and Case Western Reserve University in Cleveland.

In March, the German parent of Ben Venue and Roxane drug-making facilities in Ohio — Boehringer Ingelheim — launched a $135 million venture fund to foster innovation in the life sciences. Both the Philips and Boehringer Ingelheim moves illustrate the concept of open innovation, that is, investing in external as well as internal ideas to move companies and industries forward.

Philips’ investment in Gilde Healthcare III “is in line with its policy of open innovation and its belief that the most effective way to deploy venture capital is via an independent fund that can leverage the expertise of a professional fund manager and the other investors,” the company said. The investment will complement Philips’ innovation efforts, which include the Philips Healthcare Incubator.

“Over the past years, the venturing community has been instrumental in bringing breakthrough healthcare innovations to the market,” said Steve Rusckowski, CEO of Philips Healthcare, in his company’s release.

“Through our participation in the Gilde Healthcare III venture capital fund, we are taking another step forward in driving innovation in areas of strategic interest to Philips in healthcare,” Rusckowski said. “At the same time, we will become even more connected to the venturing community, which is an important element of Philips’ open innovation approach.”

Gilde Healthcare Partners will manage the fund. The Dutch venture and growth capital firm manages about $400 million in investments.

Filed Under: Business/Financial News, News Well Tagged With: Philips, Venture Capital/Private Equity

More recent news

  • Johnson & Johnson MedTech launches new Volt plating systems for radius, humerus
  • PharmaSens, SiBionics collab on all-in-one insulin patch pump
  • Beta Bionics to pair iLet automated insulin delivery system with Abbott’s dual glucose-ketone sensor
  • Anaconda Biomed wins CE mark for funnel catheter
  • FDA approves Neuspera neuromod for urinary incontinence

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy